Sandra Johnson, MD
Dermatology · Fort Smith, ARNPI 1447256102
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $420,265 of the $542,904 with a category attached, or 77.4%. 39 manufacturers reported payments, led by Amgen at 27.3% of the total. Among dermatology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,349 payments — averaging $402.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$148K
- Sanofi$86K
- Dermavant Sciences, Inc.$77K
- Regeneron Healthcare Solutions, Inc.$64K
- AbbVie$45K
- Bristol Myers Squibb$36K
- plus $87K from 33 others
Across 2,003 payments — averaging $2976.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$1.5M
- Eli Lilly$1.1M
- Nielsen Biosciences, Inc.$481K
- Takeda Pharmaceuticals U.S.A., Inc.$430K
- Aclaris Therapeutics, Inc.$347K
- Incyte Corporation$338K
- plus $1.8M from 15 others
What the payments were for
- Consulting fees$57,99511%
- Speaking & faculty fees$420,26577%
- Travel & lodging$41,0088%
- Food & beverage$23,0444%
- Education$5920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$542,904 in reported general payments places this provider in the 95th percentile of 75 dermatology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 154 | $3,561 |
| Fluorouracil | 40 | $3,030 |
| Doxycycline Hyclate | 141 | $2,765 |
| Ketoconazole | 98 | $2,353 |
| Tacrolimus | 20 | $2,271 |
| Metronidazole | 26 | $2,088 |
| Calcipotriene | 14 | $2,057 |
| Triamcinolone Acetonide | 166 | $1,665 |
| ValacyclovirValacyclovir Hcl | 99 | $1,648 |
| Mupirocin | 131 | $1,058 |
| Mycophenolate Mofetil | 22 | $837 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $681 |
| Clobetasol Propionate | 21 | $566 |
| Gabapentin | 62 | $545 |
| Minoxidil | 53 | $343 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fort Smith
- Phillip StitesFort Smith$15K
- Chelsea MeltzerFort Smith$11K
- Katie WadlingtonFort Smith$6K
- George LewisFort Smith$6K
- Sara LambFort Smith$3K
- Arjun SainiFort Smith$2K
- Cyril SevernsFort Smith$950
- Scott JacksonFayetteville$533K
- Mildred CliftonBentonville$92K
- Lance HenryFayetteville$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.